Out-of Pocket Payments With Lymphedema in France

Out-of Pocket Payments in Patients With Lymphedema in France and Inequities of Access ti Healthcare

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02988505

Acronym

Lymphorac

Enrollment

260

Registered

2016-12-09

Start date

2014-09-03

Completion date

2017-12-31

Last updated

2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Lymphedema Secondary Lymphedema

Brief summary

Lymphedema is a frequent and chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. Our aim was to analyze the distributive effects of OOPP for lymphedema patients in France. A prospective, multicenter study will be conducted in France in 2014 on patients with lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. We will combine concentration curves and concentration indices to assess the distributive effects.

Interventions

OTHERStandard care

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patient aged over six years, with primary or secondary lymphedema, regardless of the severity of the disease; * Patient treated in one of the centres participating in the study; * Patient (and her legal representative for minors) who gave her written consent \[or did not refuse to participate, according to local Law\] ; * Patient with Internet access and an active email address.

Exclusion criteria

* Patients with concomitant chronic venous insufficiency; * Patient not covered by any health care insurance scheme; * People protected under the law.

Design outcomes

Primary

Measure	Time frame
The mean monthly out-of-pocket payment as assessed by an online self-questionnaire	6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026